anti-EpCAM/anti-4-1BB bispecific antibody BNT314
Term · Oncology and biomedicine · MLC-T-ONC-010634
An Fc-inert bispecific antibody directed against the tumor-associated antigen (TAA) human epithelial cell adhesion molecule (Ep-CAM; EpCAM; CD326) and the costimulatory receptor 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9; TNFRSF9), with potential immunostimulating and antineoplastic activities. Upon administration, anti-EpCAM/anti-4-1BB bispecific antibody BNT314 simultaneously targets and binds to both EpCAM expressed on tumor cells and 4-1BB expressed on a variety of leukocyte subsets including activated T lymphocytes. This crosslinks EpCAM-expressing tumor cells and 4-1BB-expressing T cells, and activates 4-1BB signaling locally in the tumor microenvironment (TME). This results in cytotoxic T-cell co-stimulation and enhances T-lymphocyte-mediated anti-tumor activity. EpCAM, a cell surface protein upregulated on many tumor cell types, promotes the proliferation, migration and invasiveness of tumor cells. 4-1BB, a surface glycoprotein of the tumor necrosis factor receptor superfamily (TNFRSF), is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.
| Identifier | MLC-T-ONC-010634 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-4-1BB/anti-EpCAM bispecific antibody BNT314; anti-EpCAM/4-1BB bispecific antibody BNT314; anti-EpCAM/anti-4-1BB bispecific antibody GEN1059; DuoBody-EpCAMx4-1BB BNT314; EpCAM x 4-1BB bispecific antibody BNT314 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010634",
"term": "anti-EpCAM/anti-4-1BB bispecific antibody BNT314",
"field": "Oncology and biomedicine",
"definition": "An Fc-inert bispecific antibody directed against the tumor-associated antigen (TAA) human epithelial cell adhesion molecule (Ep-CAM; EpCAM; CD326) and the costimulatory receptor 4-1BB (CD137; tumor necrosis factor receptor superfamily member 9; TNFRSF9), with potential immunostimulating and antineoplastic activities. Upon administration, anti-EpCAM/anti-4-1BB bispecific antibody BNT314 simultaneously targets and binds to both EpCAM expressed on tumor cells and 4-1BB expressed on a variety of leukocyte subsets including activated T lymphocytes. This crosslinks EpCAM-expressing tumor cells and 4-1BB-expressing T cells, and activates 4-1BB signaling locally in the tumor microenvironment (TME). This results in cytotoxic T-cell co-stimulation and enhances T-lymphocyte-mediated anti-tumor activity. EpCAM, a cell surface protein upregulated on many tumor cell types, promotes the proliferation, migration and invasiveness of tumor cells. 4-1BB, a surface glycoprotein of the tumor necrosis factor receptor superfamily (TNFRSF), is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.",
"synonyms": [
"anti-4-1BB/anti-EpCAM bispecific antibody BNT314",
"anti-EpCAM/4-1BB bispecific antibody BNT314",
"anti-EpCAM/anti-4-1BB bispecific antibody GEN1059",
"DuoBody-EpCAMx4-1BB BNT314",
"EpCAM x 4-1BB bispecific antibody BNT314"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-epcam-anti-4-1bb-bispecific-antibody-bnt314/"
}
Record 1,731 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.